Epperla, Narendranath, Kami J. Maddocks, Mohammed Salhab, Julio C. Chavez, Nishitha Reddy, Reem Karmali, Elvira Umyarova, et al. “C-MYC-positive relapsed and refractory, diffuse large B-cell lymphoma: Impact of additional “hits” and outcomes with subsequent therapy.” Cancer 123, no. 22 (November 15, 2017): 4411–18. https://doi.org/10.1002/cncr.30895.
Landsburg, Daniel J., Marissa K. Falkiewicz, Joseph Maly, Kristie A. Blum, Christina Howlett, Tatyana Feldman, Anthony R. Mato, et al. “Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission.” Journal of Clinical Oncology 35, no. 20 (July 10, 2017): 2260–67. https://doi.org/10.1200/jco.2017.72.2157.
Costa, Luciano J., Kami Maddocks, Narendranath Epperla, Nishitha M. Reddy, Reem Karmali, Elvira Umyarova, Veronika Bachanova, et al. “Diffuse large B-cell lymphoma with primary treatment failure: Ultra-high risk features and benchmarking for experimental therapies.” American Journal of Hematology 92, no. 2 (February 2017): e24615–e24615. https://doi.org/10.1002/ajh.24615.
Costa, Cristiana A., Bassem I. Zaki, Stephanie P. Yen, Eric S. Winer, Helen Ryan, Darcie Findley, Sara R. Metzler, et al. “Short Course of Bendamustine and Rituximab Followed By 90Y-Ibritumomab Tiuxetan in Patients with Chemotherapy-Naive Follicular Lymphoma (FOL-BRITe): Final Report of Response Rates and Progression Free Survival.” In Blood, Vol. 128. AMER SOC HEMATOLOGY, 2016.